Mark For: BYONZINE® trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 90383313 |
Registration Number | 6586926 |
Mark Literal Elements | BYONZINE |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | Service Mark |
Current Location | NEW APPLICATION PROCESSING 2020-12-18 |
Basis | 44(d) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | No |
Filed ITU | No |
44D Filed | Yes |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Domestic Representative | E. Anthony Figg |
Attorney Name | E. Anthony Figg |
Attorney Docket Number | 4581-168 |
2020-12-15 | Application Filed |
2020-12-18 | Location: NEW APPLICATION PROCESSING |
2020-12-18 | Status: Live/Pending |
2020-12-18 | Status: New application will be assigned to an examining attorney approximately 3 months after filing date. |
2020-12-18 | Transaction Date |
2021-12-14 | Trademark Registered |
Party: | ![]() |
Address | Microweg 22 6545 CM NETHERLANDS Nijmegen |
Legal Entity Type | Limited Liability Company |
Legal Entity State | NETHERLANDS |
![]() | MULTI | 2020-12-15 |
![]() | JPEG | 2020-12-15 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0421 | Scientific and technological services, including associated research services; pharmaceutical research and development; biomedical research; medical research; chemical and biological laboratory services; scientific laboratory services relating to pharmaceuticals; Development of pharmaceutical products and ingredients; laboratory research and analysis; research and design services for the pharmaceutical industry; research and development of new products for others; research into new drugs; Research in the field of proteins, antibodies, microorganisms and cells; research and development in antibody technology; design and development of medical technologies; research and development of antibody conjugates combined with a drug or chemical for the treatment of cancer |
GS0421 | Scientific and technological services, namely, scientific research, analysis, testing, diagnostic testing in the field of medicine, namely, cancers and autoimmune diseases, and the treatment of illnesses; Pharmaceutical research and development; biomedical research; medical research; scientific chemical and biological laboratory services; scientific laboratory services relating to pharmaceuticals; Development of pharmaceutical products and ingredients; laboratory research and analysis, namely, chemical research and analysis, biological research and analysis; research and design services for the pharmaceutical industry; research and development of new products for others; research into new drugs, namely, pharmaceutical drug development services; research and design services for the pharmaceutical industry; research and development of new products for others; research into new drugs, namely, pharmaceutical drug development services; Scientific research in the field of proteins, antibodies, microorganisms and cells; Scientific research and development in antibody technology; design and development of medical technologies; research and development of antibody conjugates combined with a drug or chemical for the treatment of cancer |
Description | Date | Proceeding Number |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2020-12-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.